Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Adicet Bio, Inc. 0HX7.L
$6.39
-$0.72 (-11.32%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3404514.00000000
-
week52high
21.20
-
week52low
6.61
-
Revenue
-
P/E TTM
0
-
Beta
1.91361000
-
EPS
-1.04900000
-
Last Dividend
0.28500000
-
Next Earnings Date
10 мая 2023 г. в 20:10
Описание компании
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии